Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of prescribing cannabis-based medicinal products through the NHS to treat (a) autism spectrum disorder and (b) attention deficit hyperactivity disorder.

The Department has made no such assessment.

Decisions relating to the prescribing of cannabis-based medicines are made on a case-by-case basis and whether to treat remains a clinical decision. The Department has been clear that where a cannabis-based medicinal product is appropriately prescribed, the patient must be able to access it.